Search Results

Deals

Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business

Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, announced the completion of their previously announced acquisition of Baxter International Inc.’s BioPharma Solutions business.

October 2, 2023

·

4 min read

BioMidwest

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Baxter International Inc., a leading global medtech company, announced that it has signed a definitive agreement to divest its BioPharma Solutions business to Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

May 8, 2023

·

9 min read

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million

Ono Pharmaceutical Co., Ltd. announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P., which was established as a corporate venture capital fund in CA, USA in May 2020.

December 1, 2023

·

1 min read

Pictured: A sign on a J.P. Morgan building in Hong Kong/iStock, danielvfung

J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund

J.P. Morgan’s life sciences venture capital arm on Thursday announced it closed its first biotech fund, targeting companies in cardiometabolic disease, immunology, oncology and genetic medicine.

June 14, 2024

·

2 min read

·

Tyler Patchen

Biotech Bay

Bioluminescence Ventures Emerges from Stealth with $477M AUM

Bioluminescence Ventures today announced its emergence from stealth with $477M in assets under management across two funds: Bioluminescence Ventures Fund I, L.P., and Bioluminescence Ventures Fund II, L.P.

November 1, 2023

·

5 min read

Press Releases

Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma

December 12, 2024

·

5 min read

Pharm Country

Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection

Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.

March 27, 2024

·

7 min read

Policy

Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release

Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. have entered into a binding settlement agreement and mutual release settling ongoing litigation.

December 1, 2023

·

6 min read

Business

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

Daxor Corporation today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer.

June 5, 2024

·

4 min read

A top-down view of a business team holding a meeting

Startups

BridgeBio Launches GondolaBio With $300M, Transfers Programs to Joint Venture

With the help of third-party investors, the new venture will focus on three genetic and rare diseases: tuberous sclerosis complex, erythropoietic protoporphyria and alpha-A1 antitrypsin deficiency.

August 22, 2024

·

2 min read

·

Tristan Manalac